Erratum: Overexpression of mutated Cu,Zn-SOD in neuroblastoma cells results in cytoskeletal change (American Journal of Physiology - Cell Physiology (February 2005) 288 (C253-C259) DOI: 10.1152/ajpcell.00014.2004);Overexpression of mutated Cu,Zn-SOD in neuroblastoma cells results in cytoskeletal change

American Journal of Physiology - Cell Physiology

Volumn 288, Issue 2 57-2, 2005, Pages

  Takamiya, Rina ^a   Takahashi, Motoko ^a   Park, Yong Seek ^a   Tawara, Yoshie ^a   Fujiwara, Noriko ^b   Miyamoto, Yasuhide ^a   Gu, Jianguo ^a   Suzuki, Keiichiro ^b   Taniguchi, Naoyuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Copper; G 2 M arrest; Neurodegenerative disease; Zinc superoxide dismutase

Indexed keywords

ACTIN; COPPER ZINC SUPEROXIDE DISMUTASE; PHALLOIDIN;

ARTICLE; CELL CYCLE; CELL GROWTH; CYTOSKELETON; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH RETARDATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NEUROBLASTOMA CELL; PRIORITY JOURNAL; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; WILD TYPE;

EID: 12144266372     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00122.2005     Document Type: Erratum

References (38)

1. Andersen PM, Morita M, and Brown RH Jr. Genetics of Amyotrophic Lateral Sclerosis: An Overview. London: World Federation of Neurology, Committee on Motor Neuron Disease, 1999.
2. Arai K, Maguchi S, Fujii S, Ishibashi H, Oikawa K, and Taniguchi N. Glycation and inactivation of human Cu-Zn-superoxide dismutase: identification of the in vitro glycated sites. J Biol Chem 262: 16969-16972, 1987.
3. Banan A, Fitzpatrick L, Zhang Y, and Keshavarzian A. OPC-compounds prevent oxidant-induced carbonylation and depolymerization of the F-actin cytoskeleton and intestinal barrier hyperpermeability. Free Radic Biol Med 30: 287-298, 2001.
4. Banan A, Zhang Y, Losurdo J, and Keshavarzian A. Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonie cell line. Gut 46: 830-837, 2000.
5. Beckman JS, Carson M, Smith CD, and Koppenol WH. ALS, SOD and peroxynitrite. Nature 364: 584, 1993.
6. Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, and Cleveland DW. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18: 327-338, 1997.
7. Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E, Reaume AG, Scott RW, and Cleveland DW. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281: 1851-1854, 1998.
8. Bucciantini M, Giannoni E, Chili F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, and Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416: 507-511, 2002.
9. Burke JR, Enghild JJ, Martin ME, Jou YS, Myers RM, Roses AD, Vance JM, and Strittmatter WJ. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med 1: 347-350, 1996.
10. Cleveland DW and Rothstein JD. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2: 806-819, 2001.
11. Durham HD, Roy J, Dong L, and Figlewicz DA. Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J Neuropathol Exp Neurol 56: 523-530, 1997.
12. Farah CA, Nguyen MD, Julien JP, and Leclerc N. Altered levels and distribution of microtubule-associated proteins before disease onset in a mouse model of amyotrophic lateral sclerosis. J Neurochem 84: 77-86, 2003.
13. Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, Kowall NW, Brown RH Jr, and Beal MF. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 69: 2064-2074, 1997.
14. Fujii J, Myint T, Seo HG, Kayanoki Y, Ikeda Y, and Taniguchi N. Characterization of wild-type and amyotrophic lateral sclerosis-related mutant Cu,Zn-superoxide dismutases overproduced in baculovirus-infected insect cells. J Neurochem 64: 1456-1461, 1995.
15. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, Chen W, Zhai P, Sufit RL, and Siddique T. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264: 1772-1775, 1994.
16. Hart PJ, Liu H, Pellegrini M, Nersissian AM, Gralla EB, Valentine JS, and Eisenberg D. Subunit asymmetry in the three-dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosis. Protein Sci 7: 545-555, 1998.
17. Hirano A, Nakano I, Kurland LT, Mulder DW, Holley PW, and Saccomanno G. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 43: 471-480, 1984.
18. Johnston JA, Dalton MJ, Gurney ME, and Kopito RR. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 97: 12571-12576, 2000.
19. Julien JP. Amyotrophic lateral sclerosis: unfolding the toxicity of the misfolded. Cell 104: 581-591, 2001.
20. Koide T, Igarashi S, Kikugawa K, Nakano R, Inuzuka T, Yamada M, Takahashi H, and Tsuji S. Formation of granular cytoplasmic aggregates in COS7 cells expressing mutant Cu/Zn superoxide dismutase associated with familial amyotrophic lateral sclerosis. Neurosci Lett 257: 29-32, 1998.
21. Kunst CB, Mezey E, Brownstein MJ, and Patterson D. Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions. Nat Genet 15: 91-94, 1997.
22. Lee PJ, Alam J, Wiegand GW, and Choi AM. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc Natl Acad Sci USA 93: 10393-10398, 1996.
23. Li XJ, Li SH, Sharp AH, and Nucifora FC Jr, Schilling G, Lanahan A, Worley P, Snyder SH, and Ross CA. A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378: 398-402, 1995.
24. Mourelatos Z, Gonatas NK, Stieber A, Gurney ME, and Dal Canto MC. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc Natl Acad Sci USA 93: 5472-5477, 1996.
25. Nguyen MD, Boudreau M, Kriz J, Couillard-Després S, Kaplan DR, and Julien JP. Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1. J Neurosci 23: 2131-2140, 2003.
26. Okado-Matsumoto A, Myint T, Fujii J, and Taniguchi N. Gain in functions of mutant Cu,Zn-superoxide dismutases as a causative factor in familial amyotrophic lateral sclerosis: less reactive oxidant formation but high spontaneous aggregation and precipitation. Free Radic Res 33: 65-73, 2000.
27. Ookawara T, Kawamura N, Kitagawa Y, and Taniguchi N. Site-specific and random fragmentation of Cu,Zn-superoxide dismutase by glycation reaction: Implication of reactive oxygen species. J Biol Chem 267: 18505-18510, 1992.
28. Pasinelli P, Belford ME, Lennon N, Bacskai BJ, Hyman BT, Trotti D, and Brown RH Jr. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43: 19-30, 2004.
29. Rakhit R, Cunningham P, Furtos-Matei A, Dahan S, Qi XF, Crow JP, Cashman NR, Kondejewski LH, and Chakrabartty A. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J Biol Chem 277: 47551-47556, 2002.
30. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, van den Bergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haine J, Rouleau GA, Gusella JS, Horritz HR, and Brown RH Jr. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62, 1993.
31. Rouleau GA, Clark AW, Rooke K, Pramatarova A, Krizus A, Suchowersky O, Julien JP, and Figlewicz D. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann Neurol 39: 128-131, 1996.
32. Sato Y, Takahashi M, Shibukawa Y, Jain SK, Hamaoka R, Miyagawa J, Yaginuma Y, Honke K, Ishikawa M, and Taniguchi N. Overexpression of N-acetylglucosaminyltransferase III enhances the epidermal growth factor-induced phosphorylation of ERK in HeLaS3 cells by upregulation of the internalization rate of the receptors. J Biol Chem 276: 11956-11962, 2001.
33. Suzuki T, Oishi M, Marshak DR, Czernik AJ, Nairn AC, and Greengard P. Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBO J 13: 1114-1122, 1994.
34. Takamiya R, Takahashi M, Myint T, Park YS, Miyazawa N, Endo T, Fujiwara N, Sakiyama H, Misonou Y, Miyamoto Y, Fujii J, and Taniguchi N. Glycation proceeds faster in mutated Cu, Zn-superoxide dismutases related to familial amyotrophic lateral sclerosis. FASEB J 17: 938-940, 2003.
35. Vukosavic S, Stefanis L, Jackson-Lewis V, Guégan C, Romero N, Chen C, Dubois-Dauphin M, and Przedborski S. Delaying caspase activation by Bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci 20: 9119-9125, 2000.
36. Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, Lee MK, Valentine JS, and Bredesen DE. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271: 515-518, 1996.
37. Williamson TL and Cleveland DW. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci 2: 50-56, 1999.
38. Yim MB, Kang JH, Yim HS, Kwak HS, Chock PB, and Stadtman ER. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc Natl Acad Sci USA 93: 5709-5714, 1996.